Skip to content

Prevention of urological complications in living kidney transplantation: stenting or not?

Prevention of urological complications in living kidney transplantation: stenting or not? - SPLINT-trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41447
Enrollment
200
Registered
2014-01-22
Start date
2014-04-08
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nier transplantatie kidney transplantation urological complications

Interventions

Nowadays, our clinical practice is the use of a stent in case of kidney transplantations from a living kidney donation. Our *intervention* will be the non-use of a stent. Alongside, we will ask the

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants who will receive a living donor kidney transplantation and speak the Dutch language sufficiently to sign the informed consent forms and to fill in the questionnaires.

Exclusion criteria

Exclusion criteria: - Patients with a reconstructed urinary tract or conduit after total or partial cystectomy. - Patients with bladder dysfunction that requires continuous or intermittent catheterization. - Age

Design outcomes

Primary

MeasureTime frame
Percutaneous Nephrostomy placement

Secondary

MeasureTime frame
Urinary tract infection Haematuria Radiological interventions Surgical re-interventions Stent obstruction or dysfunction Additionally, a quality of life and cost effectiveness analysis will be preformed with questionnaires. Validated questionnaires for quality of life, health state, work efforts and disabilities in daily life are measured by the Euro-Qol, SF-36 and *Werk en Zorg*.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)